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Makoto Kanai1, Hiroshi Kurita1, Tanri shiozawa2, Yozo Nakazawa  3, Teruomi tsukahara1,4, 
tetsuo Nomiyama1,4 & the Japan environment & Children’s study (JeCs) Group*
There have been no large nationwide birth cohort studies examining for the effects of maternal alcohol 
use during pregnancy on placental abnormality. this study searched for associations between alcohol 
consumption and the placental abnormalities of placenta previa, placental abruption, and placenta 
accreta using the fixed dataset of a large national birth cohort study commencing in 2011 that included 
80,020 mothers with a singleton pregnancy. The presence of placental abnormalities and potential 
confounding factors were recorded, and multiple logistic regression analysis was employed to search 
for correlations between maternal alcohol consumption during pregnancy and placental abnormalities. 
The overall rate of prenatal drinking until the second/third trimester was 2.7% (2,112). The prevalence 
of placenta previa, placental abruption, and placenta accreta was 0.58% (467), 0.43% (342), and 0.20% 
(160), respectively. After controlling for potential confounding factors, maternal alcohol use during 
pregnancy was significantly associated with the development of placenta accreta (OR 3.10, 95%CI 1.69-
5.44). In conclusion, this large nationwide survey revealed an association between maternal drinking 
during pregnancy and placenta accreta, which may lead to excessive bleeding during delivery.
The placenta plays a crucial role in maternal-fetal exchange. Abnormalities of the placenta have been linked to 
such pregnancy complications as placental abruption, placenta previa, and placenta accreta1. Placental abruption 
is responsible for up to a third of all perinatal deaths2, mainly owing to the disruption of gestation length and 
fetal growth3,4. Placenta previa can also restrict fetal growth and cause preterm delivery and perinatal mortality5. 
Placenta accreta is associated with premature birth and excessive vaginal bleeding during delivery6.
By readily crossing the placenta, alcohol may play a role in vascular lesion development leading to unfa-
vorable outcomes. Specifically, dose-dependent alcohol exposure produces placental vasoconstriction and lower 
placental weight7,8. Alcohol may also alter important embryonic processes to impair normal development and 
lead to morbidity or mortality8,9. In one survey, only 1.6% of pregnant women reported frequent drinking, but 
roughly 12.5% described having at least some alcohol in pregnancy8. Most studies largely corroborate associations 
between alcohol and adverse pregnancy outcomes, but there is a lack of consensus regarding the relationship 
between maternal alcohol use and placental abnormality. Salihu et al.10 and Aliyu et al.11 previously examined for 
associations between prenatal alcohol consumption and the occurrence of placenta-associated syndromes that 
included placenta previa and placental abruption, but neither study evaluated for placenta accreta. Even though 
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these previous studies had sufficient sample size, alcohol exposure might be underreported, biasing study results 
toward the null.
This large birth cohort study12 was conducted with two main goals: (1) clarify the effect of prenatal alcohol 
consumption on the risk of placenta previa, placental abruption, and placenta accreta, and (2) assess for dose 
dependencies between alcohol use and placental abnormality.
Results
A total of 80,020 mothers with singleton births who completed the questionnaire were available for analysis. The 
overall rate of prenatal drinking until the second/third trimester was 2.7% (2,112). The prevalence of placenta 
previa, placental abruption, and placenta accreta were 0.58% (467), 0.43% (342), and 0.20% (160), respectively.
Table 1 summarizes the participants’ characteristics and alcohol exposure stratified by placental abnormalities 
(no placental abnormalities [controls], placenta previa, placental abruption, and placenta accreta). There were 
significant differences among the groups with regard to maternal age, past history of cesarean section, recurrent 
pregnancy loss, means of pregnancy, and smoking status. Significant differences also existed for maternal drink-
ing status.
In multivariate logistic regression analysis after adjustment for covariates, we observed no remarkable dif-
ferences in alcohol consumption during pregnancy as compared with controls for placenta previa or placental 
abruption. However, maternal drinking was significantly associated with placenta accreta (adjusted odds ratio 
[aOR] 3.03, 95% confidence interval [CI] 1.69–5.44). Regarding the frequency of alcohol consumption, infre-
quent (<3 days a week) and frequent (3+ days a week) drinking were also related to the incidence of placenta 
accreta (aOR 3.02, 95%CI 1.52–5.99 and aOR 3.06, 95%CI 1.11–8.48, respectively). Focusing on the amount of 
alcohol consumption, we observed significant differences for a low amount (<1.5 drinks a week) of drinking as 
compared with controls for placenta accreta (aOR 3.18, 95%CI 1.65–6.11). There were no associations between 
high drinking amounts during pregnancy and placental abnormalities (Table 2), although increases in the fre-












Participants, n 79,051 467 342 160
Maternal age at delivery, years (mean ± SD) 31.2 ± 5.1 33.5 ± 4.7 b 32.0 ± 5.2 b c 32.3 ± 5.2b <0.001a
Maternal age group, n (%)
   <20 years 674 (0.9) 0 (0.0) 5 (1.5) 0 (0.0)
   20–34 years 56,798 (71.8) 250 (53.5) 216 (63.2) 96 (60.0)
   35 + years 21,579 (27.3) 217 (46.5) 121 (35.4) 64 (40.0) <0.001
Maternal BMI before pregnancy, kg/m2 
(mean ± SD) 21.2 ± 3.3 21.3 ± 3.2 21.6 ± 3.7 21.6 ± 3.4 0.10
a
Maternal BMI group
   Underweight (BMI < 18.5), n (%) 12,781 (16.2) 66 (14.1) 57 (16.7) 25 (15.6)
   Normal weight BMI 18.5–24.9), n (%) 57,911 (73.3) 350 (74.9) 239 (69.9) 115 (71.9)
   Overweight (BMI 25.0+), n (%) 8,359 (10.6) 51 (10.9) 46 (13.5) 20 (12.5) 0.51
Parity
   Multiparous, n (%) 45,402 (57.4) 276 (59.1) 193 (56.4) 96 (60.0) 0.78
Past history of cesarean section, n (%) 6,968 (8.8) 56 (12.0) 47 (13.7) 8 (5.0) <0.001
Recurrent pregnancy loss, n (%) 813 (1.0) 11 (2.4) 3 (0.9) 2 (1.3) 0.043
Means of pregnancy for current birth, n (%)
   Spontaneous 73,967 (93.6) 394 (84.4) 310 (90.6) 123 (76.9)
   Ovulation induction through medication 2,112 (2.7) 17 (3.6) 7 (2.0) 3 (1.9)
   Artificial insemination or in-vitro fertilization 2,972 (3.8) 56 (12.0) 25 (7.3) 34 (21.3) <0.001
Smoking during pregnancy, n (%) 3,572 (4.5) 17 (3.6) 26 (7.6) 14 (8.8) 0.002
Drinking during pregnancy, n (%) 2,012 (2.5) 10 (2.1) 8 (2.3) 13 (8.1) <0.001
Maternal drinking frequency, n (%)
   Infrequent (<3 days per week) 1438 (1.8) 6 (1.3) 4 (1.2) 9 (8.3)
   Frequent (3+ days per week) 574 (0.3) 4 (0.9) 4 (1.2) 4 (2.5) 0.001
Maternal drinking amount, n (%)
   Low (<1.5 drinks per week) 1508 (1.9) 6 (1.3) 4 (1.2) 10 (6.3)
   High (1.5+ drinks per week) 504 (0.6) 4 (0.9) 4 (1.2) 3 (1.9) 0.001
Table 1. Characteristics of participants with or without placental abnormality. aDifferences in maternal age and 
BMI were assessed with one-way repeated measures of ANOVA followed by post-hoc (Bonferroni) testing. bP-
value < 0.001 vs. group of no placental abnormality. cP-value < 0.001 vs. group of placental previa.
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Discussion
This study represents the first Japanese nationwide birth cohort study assessing the influence of maternal alcohol 
consumption in pregnancy on the placental abnormalities of placenta previa, placental abruption, and placenta 
accreta. This large study indicates a significant association between maternal drinking during pregnancy and the 
incidence of placenta accreta.
In this nationwide self-reported survey, 2.7% of mothers responded to have consumed alcohol even after 
awareness of their pregnancy. Previous Japanese birth cohort studies described higher rates of drinking (11.8%13 
and 13.4%14), which might have been due to our definition of drinkers who answered they drank up to the sec-
ond/third trimester and exclusion of past drinkers who quit drinking early in pregnancy. Although this study 
included very few frequent or heavy drinkers among responders, dose-response and frequency-response trends 
were found between alcohol consumption and the development of placenta accreta.
Placenta previa, placental abruption, and placenta accreta were found to complicate 0.58%, 0.43%, and 0.20%, 
respectively, of singleton births, with prevalence rates similar to those of earlier reports. However, rates can differ 
among regions and races15–23.
Verification of sufficient analytical power was confirmed for the JECS cohort. In this scenario, testing a 
hypothesis for a disorder with a 0.1% prevalence, such as Down syndrome, 2.0 relative risk, and 0.05 alpha error 
using a sample in which the rate of individuals with high exposure to the studied chemical substance is 25% 
requires a cohort of 64,536 participants for a statistical power of 80%12. The JECS sample size exceeded this 
number.
Previous studies showed that maternal alcohol consumption increased the risk of placental abruption, but 
not of placenta previa10,11. Salihu et al.10 detected a significant positive correlation between alcohol consumption 
during pregnancy and placental abruption, although placenta previa was not remarkably linked to alcohol use 
during pregnancy. They also uncovered a J-shaped increase curve for placental abruption with increasing prenatal 
alcohol use. Similarly, Aliyu et al.11 found that mothers who consumed alcohol during pregnancy had an elevated 
risk of placental abruption, but not placenta previa. Yang et al.16 demonstrated that the effects of maternal drink-
ing were stronger on placental abruption than on placenta previa. Unlike the present report, however, placenta 
accreta was not included in the above studies. Our findings revealed a significant association between maternal 
alcohol consumption during pregnancy and the outcome of placenta accreta, with none for placenta previa or 
placental abruption. In this regard, it provides new information on the relationship between placental abnormal-
ities and drinking.
Maternal alcohol exposure during pregnancy may be a significant risk factor for placenta accreta, but the 
pathway of this phenomenon is not fully understood. Trophoblast invasion into the uterus is a key process dur-
ing human placentation. In mice, perigestational alcohol exposure at organogenesis induced oxidative stress 
in the myometrium and trophoblast-decidual tissue, mainly affecting cells and macromolecules of tropho-
blasts and decidual tissues associated with placental formation24. Han et al.25 revealed that exposure to ethanol 
augmented the expression of nonmuscle myosin heavy chain-II (NMHC-II) associated with cell migration in 
human first-trimester trophoblast cell line HTR-8/SVneo extravillous trophoblast cells. In mouse models, they 
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Maternal drinking frequency status
Non-drinkers (reference) 1.00 1.00 1.00 1.00 1.00 1.00






















P for trend 0.78 0.84 0.84 0.94 <0.001 <0.001
Maternal drinking amount status
Non-drinkers (reference) 1.00 1.00 1.00 1.00 1.00 1.00






















P for trend 0.85 0.91 0.77 0.99 <0.001 0.001
Table 2. Multivariate logistic regression analysis for placental abnormalities versus controls. Multiple logistic 
regression model was adjusted for maternal age, BMI before pregnancy, menstrual abnormality, recurrent 
pregnancy loss, parity, history of delivery (including cesarean section and artificial abortion), means of 
pregnancy, smoking habit, complications during pregnancy (including antiphospholipid antibody syndrome, 
maternal infection, diabetes mellitus/gestational diabetes mellitus, and hypertensive disorder of pregnancy), 
and medications during pregnancy (including antibiotics, iron supplements, folic acid supplements, and therapy 
for recurrent pregnancy loss).
4Scientific RepoRts |         (2019) 9:10259  | https://doi.org/10.1038/s41598-019-46760-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
also demonstrated that acute ethanol exposure induced significant upregulation of NMHC-IIB expression in all 
regions of the placenta compared with control placental tissue. These findings might partially explain the mecha-
nism underlying a predisposition to placenta accreta by maternal alcohol use.
In this study, the incidence of prior cesarean section in the accreta group was 5% and less than that in normal 
controls. We did not observe a significant positive relationship between placenta accreta and uterine scarring 
from previous cesarean delivery. Prior cesarean delivery was reported as a risk factor for placenta accreta or 
accreta with previa20,26,27. Other developed countries have a higher rate of cesarean delivery (20–29%)28–30 than in 
Japan, which tends to increase with the incidence of placenta accreta26. In the present investigation, the incidence 
of previous cesarean delivery was 12.3% for placenta accreta complicated with other placental abnormalities. The 
exclusion of cases with multiple placental abnormalities and the low rate of cesarean section in this cohort study 
were considered the reasons for a lower incidence of cesarean section in placenta accreta.
This study has several limitations. The data regarding alcohol consumption were collected from self-reported 
questionnaires and therefore subjective. Since the participants were part of a long-term cohort study, some selec-
tion bias might have been included. This study also did not account for regional differences in drinking hab-
its. Another limitation was the lack of detailed information on the diagnosis of placental abnormalities because 
obstetricians recorded only the presence of abnormalities at birth from medical records; there may have been 
differences in the diagnostic criteria and degree of placental abnormality. Thus, misclassifications causing a bias 
towards the null value could have occurred. In the protocol of the JECS, misclassifications were regarded as equal 
to environmental toxin exposure since the raters were blinded to assessments12. Such misclassifications might 
have expanded the 95%CI.
In spite of the above limitations, this first study using a dataset from a Japanese nationwide birth cohort sur-
vey evaluated the impact of alcohol consumption in pregnancy while controlling for confounders identified by 
previous reports. It provides crucial evidence on the adverse effects of maternal alcohol exposure on placental 
abnormality.
In conclusion, this investigation uncovered a significant association between maternal alcohol consumption 
during pregnancy and placenta accreta, but not placenta previa or placental abruption. Although the study con-
tained few frequent or heavy drinkers among responders, it detected dose-response as well as frequency-response 
tendencies of alcohol consumption on the development of placenta accreta. Further investigations are warranted 
to clarify the mechanisms underlying the detrimental effects of alcohol on placental pathogenesis.
Materials and Methods
study design and participants. The data used in this investigation were adopted from the Japan 
Environment and Children’s Study (JECS), an ongoing cohort study commencing in January 2011 to assess the 
impact of environmental factors on children’s health.
In the JECS, pregnant women were enrolled between January 2011 and March 2014 under the following 
inclusion criteria: (1) living in the study region at the time of enrollment, (2) delivery expected later than August 
1, 2011, and (3) able to understand Japanese and fill out the self-administered survey. Details on the JECS project 
are available elsewhere31,32. The current study employed the “jecs-ag-20160424” dataset that was issued in June 
2016 containing information on 96,476 mothers who had a singleton pregnancy. We analyzed data regarding 
alcohol consumption habits self-described by respondents during the second/third trimester, worded as follows: 
(1) no alcohol consumption, (2) quit drinking before pregnancy, (3) quit drinking during early pregnancy, and 
(4) drank during pregnancy. Subjects responding as (4) were further asked to describe their frequency and type 
of alcohol consumption. Information from medical record transcriptions regarding additional pregnancy details 
and medical history were used as other covariates. Of all the mothers who began the study, 80,020 (77.6%) com-
pleted the questionnaire (Fig. 1).
The Ministry of the Environment’s Institutional Review Board on Epidemiological Studies, and the Ethics 
Committees of all participating institutions approved the JECS protpcol31. The JECS was conducted in accordance 
with the Helsinki Declaration and other nationally valid regulations and guidelines. Written informed content 
was obtained from each participant.
Data collection. Information on the alcohol consumption habits of mothers was collected during the sec-
ond/third trimester of pregnancy from self-reported questionnaires. Maternal anthropometric data before preg-
nancy, complications and medication during pregnancy that included placental abnormalities, hypertensive 
disorders of pregnancy (HDP), and diabetes mellitus/gestational diabetes mellitus (DM/GDM), and a history of 
previous pregnancy were collected by the subjects’ obstetricians. Pre-pregnancy body mass index (BMI) was used 
to evaluate maternal weight status and was calculated according to World Health Organization Standards (body 
weight [kg]/height [m]2).
Outcomes, exposure, and covariates. The main outcomes of interest were placenta previa, placental 
abruption, and placenta accreta. Placenta previa was judged as the placenta being attached to the uterine wall 
covering the internal os. This obstetric complication typically occurs in the late first trimester and may resolve 
later in pregnancy from so-called placental migration33. Placental abruption was determined as all or a part of 
the placenta pulling away from the uterine wall to hinder fetal blood and oxygen delivery. Small abruptions are 
able to resolve spontaneously, although larger ones may result in fetal distress or death11. We defined placenta 
accreta as abnormal uterine musculature attachment or invasion of placental tissue. Severe postpartum bleeding 
may result from failure of placental separation from the uterus after delivery, which has been associated with 
higher maternal morbidity and mortality6. We excluded 33 participants who became complicated with 2 or more 
placental abnormalities.
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Alcohol consumption was assessed with a semi-quantitative food frequency questionnaire that contained 
a list of foods with standard portion sizes commonly consumed in Japan34. Regarding alcohol consumption, 
respondents indicating that they continued drinking throughout pregnancy were asked how often they drank and 
how many of what drinks they consumed. The frequency of maternal drinking during pregnancy was assessed 
by the questionnaire item, “Please choose an item that best describes your current drinking frequency”, and was 
grouped as follows: “hardly drank”, “once to three times a month”, “once to twice a week”, “three to four times a 
week”, five to six times a week”, and “drank everyday”. Alcohol content values for each beverage (Japanese sake, 
Japanese distilled spirits, beer, whiskey, and wine) were summated to calculate the total exposure amount of eth-
anol (g/week). We calculated the amount of ethanol as follows; 180 ml of Japanese sake contained 23 g of ethanol, 
180 ml of distilled spirits contained 36 g of ethanol, a large bottle of beer (633 ml) contained 23 g of ethanol, 30 ml 
of whiskey contained 10 g of ethanol, and 60 ml of wine contained 9 g of ethanol. Based on previously published 
reports11, we divided drinkers into infrequent drinkers (<3 days per week) and frequent drinkers (3 + days per 
week). We also categorized drinkers into the following absolute alcohol amount categories: low (<1.5 drinks/
week) and high (1.5 + drinks/week)35. The alcohol amount category of “low” included drinkers who chose the 
item of “hardly drank”. One standard drink was estimated to contain 14 g of ethanol35,36. We used non-drinking 
mothers as controls.
Demographic covariates included maternal age, smoking habit, and pre-pregnancy BMI. Obstetric and med-
ical variables, such as parity, past history of cesarean section and artificial abortion, HDP, DM/GDM, and other 
complications and medications during pregnancy were also evaluated.
statistical analysis. All statistical analyses were performed using SPSS statistical software version 24 (SPSS 
Inc., Chicago, Illinois). Differences in maternal age and pre-pregnancy BMI among the types of placental abnor-
malities were assessed by one-way repeated measures of analysis of variance (ANOVA) followed by post-hoc 
(Bonferroni) testing. We categorized all continuous and ordinal variables, such as maternal age (<20, 20–34, 
and 35+ years), pre-pregnancy BMI (<18.5, 18.5–24.9, and 25+ kg/m2), and past parturient history (number of 
deliveries, cesarean section, and artificial abortion). Analysis of variance and chi-square tests were conducted to 
compare covariates between groups stratified by category as well as the frequency or amount of alcohol consump-
tion. We used logistic regression models to generate crude odds ratios (cORs) and aORs and their 95%CIs. The 
selection of covariates in our models was done a priori according to published literature and biologic likelihood. 
We estimated the effect of alcohol consumption to adjust for maternal background, including age (<35 and 35+ 
Figure 1. Case selection flowchart.
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years), pre-pregnancy BMI, smoking habit, maternal obstetric information (menstrual abnormality, recurrent 
pregnancy loss, parity, history of artificial abortion or cesarean section, means of this pregnancy), pregnancy 
complications such as anti-phospholipid antibody syndrome, maternal infection, HDP (mild and severe), and 
DM/GDM, and medications including antibiotics, iron supplements, folic acid supplements, and treatment for 
recurrent pregnancy loss. A P-value of <0.05 was considered statistically significant.
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